Congenital Adrenal Hyperplasia Clinical Trial
Official title:
An Adult Height Prediction Model for Congenital Adrenal Hyperplasia From a National Cohort (OPALE Model Study)
Congenital Adrenal Hyperplasia (CAH) is a genetic rare disease, which alters the adrenal
production of gluco and mineralo corticoïds. The treatment consists in supplementing children
with hydrocortisone. Despite care for these children has improved substantially across
decades, short adult height (AH) still remains an important consequence of the disease. About
20% of patients have an AH below 2 standard deviations compared to their expected AH.
In the OPALE-Model study, the investigators want to collect data from a cohort of 496 CAH
French patients, born between 1970 and 1991 with a known genotype. Using their age, sex,
growth, disease, bone maturation and pubertal data, the investigators will build a model
which allows to predict their AH using data available at 8 years of age. The growth charts
built from this cohort have shown that currently used formula to calculate the predicted AH
(Bayley-Pineau's formula) is not applicable to children with CAH.
In this project, the investigators plan to compute an AH prediction model using data from
children born between 1970 and 1993, and to validate the model using data from a different
cohort (i.e. children born between 1994 and 1998). this choice was due to availability of
data for computing the model first, and in a second stage, data from more recently born
patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03687242 -
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
|
Phase 2 | |
| Active, not recruiting |
NCT04544410 -
A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH
|
Phase 2 | |
| Not yet recruiting |
NCT04087148 -
Linear Growth of Children With Congenital Adrenal Hyperplasia
|
||
| Recruiting |
NCT05687474 -
Baby Detect : Genomic Newborn Screening
|
||
| Enrolling by invitation |
NCT05162950 -
Effects and Importance of Epinephrine/Adrenalin Deficiency in CAH
|
||
| Withdrawn |
NCT03532022 -
Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy
|
Phase 3 | |
| Recruiting |
NCT02795871 -
Prenatal Dex Study
|
N/A | |
| Completed |
NCT02934399 -
Dynamic Hormone Diagnostics in Endocrine Disease
|
||
| Recruiting |
NCT04903587 -
Gonadal Changes In Congenital Adrenal Hyperplasia Patients
|
||
| Not yet recruiting |
NCT04536662 -
Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21α-hydroxylase Deficiency
|
Phase 4 | |
| Recruiting |
NCT04463316 -
GROWing Up With Rare GENEtic Syndromes
|
||
| Completed |
NCT01807364 -
Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia
|
N/A | |
| Completed |
NCT02804178 -
A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
|
Phase 2 | |
| Completed |
NCT03019614 -
An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone
|
Phase 1 | |
| Not yet recruiting |
NCT04293133 -
Final Height in Patients With CAH
|
||
| Recruiting |
NCT03897504 -
Surgical Evaluation of Using the Prepuce in Feminizing Genitoplasty
|
N/A | |
| Active, not recruiting |
NCT04806451 -
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
|
Phase 3 | |
| Completed |
NCT01875640 -
Decision Support for Parents Receiving Information About Child's Rare Disease
|
N/A | |
| Withdrawn |
NCT00485186 -
Gene Polymorphisms Influencing Steroid Synthesis and Action
|
N/A | |
| Recruiting |
NCT04890444 -
China Adrenal Disease Registry
|